ASAN FOUNDATION

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1989-06-23

Employees: 501

Market Cap: -

Website: https://ails.amc.seoul.kr

Clinical Trials

Clinical Trial for Evaluation of Ethnic Differences in Pharmacokinetics of Chloroquine, an Anti-malarial Drug

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: chloroquine phosphate 1000 mg

First Posted Date: 2011-06-06

Last Posted Date: 2015-01-26

Lead Sponsor: Asan Medical Center

Target Recruit Count: 10

Registration Number: NCT01366235

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Lactic Acidosis During Entecavir(ETV)Treatment

Phase 4

Terminated

Conditions: Lactic Acidosis

Interventions: Drug: entecavir, lamivudine

First Posted Date: 2011-05-17

Last Posted Date: 2018-05-09

Lead Sponsor: Asan Medical Center

Target Recruit Count: 5

Registration Number: NCT01354652

Long-term Benefit of Aortic Stent-graft in Patients With Distal Aortic Dissection

Phase 4

Terminated

Conditions: Aortic Dissection
Stent-graft
Aortic Aneurysm

Interventions: Procedure: Aortic stent-graft

First Posted Date: 2011-05-16

Last Posted Date: 2015-01-14

Lead Sponsor: Asan Medical Center

Target Recruit Count: 7

Registration Number: NCT01354119

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD)

Phase 4

Completed

Conditions: Crohn's Disease
Ulcerative Colitis

Interventions: Drug: Accelerated 1 hour-infusion
Drug: Accelerated 30 minutes-infusion
Drug: Standard 2 hours-infusion

First Posted Date: 2011-05-03

Last Posted Date: 2016-07-12

Lead Sponsor: Asan Medical Center

Target Recruit Count: 145

Registration Number: NCT01346826

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients

Phase 4

Completed

Conditions: Inflammatory Bowel Disease
Crohn's Disease
Ulcerative Colitis
Hepatitis A

Interventions: Biological: Epaxal Berna (virosomal hepatitis A vaccine)

First Posted Date: 2011-04-26

Last Posted Date: 2013-03-19

Lead Sponsor: Asan Medical Center

Target Recruit Count: 493

Registration Number: NCT01341808

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Functional Organ Preservation Surgery

Not Applicable

Completed

Conditions: Organ Preservation

Interventions: Procedure: FOPS
Radiation: CRT

First Posted Date: 2011-04-06

Last Posted Date: 2019-07-09

Lead Sponsor: Asan Medical Center

Target Recruit Count: 264

Registration Number: NCT01330056

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Efficacy Study of Azithromycin-based Therapy for Bronchiolitis Obliterans

Not Applicable

Terminated

Conditions: Graft vs Host Disease
Bronchiolitis Obliterans

Interventions: Drug: azithromycin + N-acetylcystein + inhaled corticosteroid

First Posted Date: 2011-04-01

Last Posted Date: 2014-07-09

Lead Sponsor: Asan Medical Center

Target Recruit Count: 6

Registration Number: NCT01327625

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Abbreviated R-CHOP in Completely Excised Stage I or II DLBCL

Phase 2

Conditions: Diffuse Large B-cell Lymphoma

Interventions: Drug: Rituximab plus CHOP Immunochemotherapy

First Posted Date: 2011-01-20

Last Posted Date: 2016-07-26

Lead Sponsor: Asan Medical Center

Target Recruit Count: 32

Registration Number: NCT01279902

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

Phase 4

Conditions: Depression

Interventions: Drug: sugar pill
Drug: Escitalopram

First Posted Date: 2011-01-19

Last Posted Date: 2014-10-09

Lead Sponsor: Asan Medical Center

Target Recruit Count: 444

Registration Number: NCT01278498

Locations: 🇰🇷
Kangwon National University Hospital, Chuncheon, Gangwon, Korea, Republic of
🇰🇷
Kwandong University College of Medicine Myongji Hospital, Gyeonggi-do, Goyang, Korea, Republic of
🇰🇷
Dong-A University Hospital, Busan, Korea, Republic of

and more 13 locations

Neoadjuvant Combined Endocrine and HER2 Target Therapy in Postmenopausal Women With ER and Her2 Positive Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Letrozole, Lapatinib

First Posted Date: 2011-01-13

Last Posted Date: 2017-08-29

Lead Sponsor: Asan Medical Center

Target Recruit Count: 25

Registration Number: NCT01275859

Locations: 🇰🇷
Asan Nedical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy